Literature DB >> 19461506

Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes.

Alena Skálová1, Radek Sima, Tomas Vanecek, Susan Muller, Marie Korabecna, Jana Nemcova, Goran Elmberger, Ilmo Leivo, Fabricio Passador-Santos, Jiri Walter, Milena Rousarova, Kristina Jedlickova, Romuald Curik, Marie Geierova, Michal Michal.   

Abstract

High-grade transformation of acinic cell carcinoma (AciCC) (previously referred to as dedifferentiation) is a rare phenomenon characterized by histologic progression of low-grade AciCC to high-grade adenocarcinoma or undifferentiated carcinoma. We report 9 new cases with immunohistochemical analysis and examination of HER-2/neu and p53 genes to further define the profile of this tumor. Histologically, the high-grade component was composed of polymorphic cells with a high mitotic rate arranged in glandular and solid growth patterns with comedonecrosis. The MIB-1 labeling indices were elevated in the high-grade component, as compared with the low grade conventional AciCC. The high-grade component of AciCC was characterized by strong membrane staining for CK18 and beta-catenin, and nuclear staining for cyclin-D1. HER-2/neu, androgen receptor, C-kit, and epidermal growth factor receptor were absent from both low-grade and high-grade components. In contrast, S-100 protein, alpha-1-antitrypsin, and lysozyme were lost only in high-grade foci of transformed AciCC. The median age was 61 years (with range from 43 to 76 y). Lymph node (LN) metastases were found in 5 of 9 cases (56%). Distant metastases to the lungs (n=4), pleura (n=2), brain (n=3), and peritoneum (n=1), and paraaortic, paratracheal, and mediastinal LNs (n=2) were observed. Six of 9 patients (66%) died from tumor dissemination, all with a median overall survival of 4.3 years (range: 1 to 9 y). The high propensity for LN metastases indicates the need for neck dissection at the time of diagnosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19461506     DOI: 10.1097/PAS.0b013e3181a38e1c

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  29 in total

Review 1.  Salivary acinic cell carcinoma: reappraisal and update.

Authors:  V Vander Poorten; A Triantafyllou; L D R Thompson; J Bishop; E Hauben; J Hunt; A Skalova; G Stenman; R P Takes; D R Gnepp; H Hellquist; B Wenig; D Bell; A Rinaldo; A Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12-19       Impact factor: 2.503

Review 2.  Basaloid/blue salivary gland tumors.

Authors:  Raja R Seethala
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

3.  Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland.

Authors:  Min-Shu Hsieh; Yung-Ming Jeng; Yi-Hsuan Lee
Journal:  Virchows Arch       Date:  2019-06-11       Impact factor: 4.064

4.  Are acinic cell carcinomas of the breast and salivary glands distinct diseases?

Authors:  Salvatore Piscuoglio; Zsolt Hodi; Nora Katabi; Elena Guerini-Rocco; Gabriel S Macedo; Charlotte K Y Ng; Marcia Edelweiss; Leticia De Mattos-Arruda; Hannah Y Wen; Emad A Rakha; Ian O Ellis; Brian P Rubin; Britta Weigelt; Jorge S Reis-Filho
Journal:  Histopathology       Date:  2015-03-23       Impact factor: 5.087

5.  Distant Metastases in Patients with Carcinoma of the Major Salivary Glands.

Authors:  Safina Ali; Robert Bryant; Frank L Palmer; Monica DiLorenzo; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2015-03-06       Impact factor: 5.344

6.  Parotid carcinoma: Current diagnostic workup and treatment.

Authors:  Vincent L M Vander Poorten; Francis Marchal; Sandra Nuyts; Paul M J Clement
Journal:  Indian J Surg Oncol       Date:  2010-11-21

Review 7.  Salivary gland carcinomas.

Authors:  Tobias Ettl; Stephan Schwarz-Furlan; Martin Gosau; Torsten E Reichert
Journal:  Oral Maxillofac Surg       Date:  2012-07-29

8.  Finding and characterizing mammary analogue secretory carcinoma of the salivary gland.

Authors:  Min Jung Jung; Joon Seon Song; Sang Yoon Kim; Soon Yuhl Nam; Jong-Lyel Roh; Seung-Ho Choi; Sung-Bae Kim; Kyung-Ja Cho
Journal:  Korean J Pathol       Date:  2013-02-25

9.  Salivary gland hybrid tumour revisited: could they represent high-grade transformation in a low-grade neoplasm?

Authors:  Henrik Hellquist; Alena Skalova; Bahram Azadeh
Journal:  Virchows Arch       Date:  2016-09-07       Impact factor: 4.064

Review 10.  Polymorphous adenocarcinoma of the salivary glands: reappraisal and update.

Authors:  Vincent Vander Poorten; Asterios Triantafyllou; Alena Skálová; Göran Stenman; Justin A Bishop; Esther Hauben; Jennifer L Hunt; Henrik Hellquist; Simon Feys; Remco De Bree; Antti A Mäkitie; Miquel Quer; Primož Strojan; Orlando Guntinas-Lichius; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-14       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.